bf/NYSE:ABT_icon.png

NYSE:ABT

Abbott Laboratories

  • Stock

USD

Last Close

112.76

30/08 20:00

Market Cap

179.27B

Beta: 0.66

Volume Today

2.33M

Avg: 5.40M

PE Ratio

34.38

PFCF: 133.28

Dividend Yield

1.86%

Payout:31.19%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
21.85B
-
20.25B
7.33%
20.41B
0.78%
20.85B
2.20%
27.39B
31.35%
30.58B
11.64%
31.90B
4.34%
34.61B
8.48%
43.08B
24.47%
43.65B
1.34%
40.11B
8.12%
cost of revenue
10.04B
-
9.22B
8.19%
8.75B
5.11%
9.02B
3.17%
12.34B
36.71%
12.71B
2.99%
13.23B
4.13%
15.00B
13.39%
18.54B
23.56%
19.14B
3.26%
20.07B
4.86%
gross profit
11.81B
-
11.03B
6.60%
11.66B
5.70%
11.83B
1.47%
15.05B
27.26%
17.87B
18.73%
18.67B
4.48%
19.61B
4.99%
24.54B
25.16%
24.51B
0.11%
20.04B
18.25%
selling and marketing expenses
general and administrative expenses
6.94B
-
6.53B
5.85%
6.79B
3.91%
6.67B
1.67%
9.12B
36.65%
9.74B
6.88%
selling general and administrative expenses
6.94B
-
6.53B
5.85%
6.79B
3.91%
6.67B
1.67%
9.12B
36.65%
9.74B
6.88%
9.77B
0.22%
9.70B
0.71%
11.32B
16.79%
11.25B
0.67%
10.88B
3.25%
research and development expenses
1.45B
-
1.34B
7.37%
1.41B
4.46%
1.42B
1.21%
2.23B
57.17%
2.30B
2.91%
2.44B
6.09%
2.42B
0.82%
2.74B
13.31%
2.89B
5.32%
2.72B
5.85%
other expenses
32M
-
-14M
143.75%
281M
2,107.14%
-945M
436.30%
1.25B
232.38%
139M
88.89%
1.94B
1,292.81%
2.13B
10.12%
2.05B
3.99%
2.01B
1.66%
479M
76.20%
cost and expenses
19.22B
-
17.65B
8.17%
17.54B
0.62%
17.67B
0.74%
25.66B
45.26%
26.93B
4.93%
27.37B
1.65%
29.25B
6.86%
34.65B
18.46%
35.29B
1.85%
33.67B
4.58%
operating expenses
9.18B
-
8.43B
8.16%
8.79B
4.28%
8.64B
1.67%
13.33B
54.18%
14.22B
6.72%
14.14B
0.57%
14.25B
0.76%
16.11B
13.09%
16.15B
0.22%
13.60B
15.77%
interest expense
90M
-
73M
18.89%
58M
20.55%
332M
472.41%
780M
134.94%
721M
7.56%
576M
20.11%
500M
13.19%
490M
2%
375M
23.47%
698M
86.13%
ebitda
3.45B
-
3.14B
9.04%
3.75B
19.39%
2.79B
25.58%
4.95B
77.49%
5.97B
20.50%
6.66B
11.60%
7.59B
14.01%
10.75B
41.58%
10.70B
0.49%
9.68B
9.52%
operating income
2.63B
-
2.60B
1.14%
2.87B
10.31%
3.19B
11.09%
1.73B
45.81%
3.65B
111.47%
4.53B
24.16%
5.36B
18.20%
8.43B
57.27%
8.36B
0.75%
6.43B
23.04%
depreciation and amortization
791M
-
555M
29.84%
601M
8.29%
550M
8.49%
1.98B
259.09%
2.18B
10.28%
2.13B
2.34%
2.23B
5.08%
2.32B
3.98%
2.33B
0.43%
3.24B
38.95%
total other income expenses net
-18M
-
-8M
55.56%
374M
4,775%
-1.44B
485.03%
1.28B
189.24%
-56M
104.36%
-455M
712.50%
-389M
14.51%
-214M
44.99%
-56M
73.83%
229M
508.93%
income before tax
2.52B
-
2.52B
0.12%
3.18B
26.41%
1.41B
55.61%
2.23B
57.89%
2.87B
28.78%
4.08B
41.91%
4.97B
21.85%
8.21B
65.28%
8.31B
1.16%
6.66B
19.77%
income tax expense
138M
-
797M
477.54%
577M
27.60%
350M
39.34%
1.88B
436.57%
539M
71.30%
390M
27.64%
497M
27.44%
1.14B
129.38%
1.37B
20.44%
941M
31.46%
net income
2.58B
-
2.28B
11.34%
4.42B
93.65%
1.40B
68.35%
477M
65.93%
2.37B
396.44%
3.69B
55.70%
4.50B
21.91%
7.07B
57.31%
6.93B
1.95%
5.72B
17.45%
weighted average shs out
1.55B
-
1.51B
2.59%
1.47B
2.35%
1.47B
0.01%
1.74B
18.38%
1.76B
0.69%
1.77B
0.71%
1.77B
0.28%
1.77B
0.11%
1.75B
1.24%
1.74B
0.74%
weighted average shs out dil
1.57B
-
1.53B
2.99%
1.51B
1.38%
1.48B
1.53%
1.75B
17.94%
1.77B
1.20%
1.78B
0.62%
1.79B
0.28%
1.79B
0.17%
1.76B
1.40%
1.75B
0.85%
eps
1.66
-
1.51
9.04%
3
98.68%
0.95
68.33%
0.27
71.58%
1.35
400%
2.07
53.33%
2.52
21.74%
3.97
57.54%
3.94
0.76%
3.28
16.75%
epsdiluted
1.64
-
1.50
8.54%
2.94
96%
0.94
68.03%
0.27
71.28%
1.34
396.30%
2.06
53.73%
2.50
21.36%
3.94
57.60%
3.91
0.76%
3.26
16.62%

All numbers in USD (except ratios and percentages)